| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $48K | — | -74.8% |
| Cost of Revenue | $33K | — | -79.5% |
| Gross Profit | $15K | — | -50.1% |
| R&D Expense | $265K | — | -28.9% |
| SG&A Expense | $487K | — | +72.3% |
| Operating Income | -$1.3M | — | -0.0% |
| Net Income | -$1.2M | — | +0.4% |
| EPS (Basic) | -$1.48 | — | -770.6% |
| EPS (Diluted) | -$1.48 | — | -770.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $10K | +35.4% | -3.3% |
| Inventory | $91K | -9.1% | +41.6% |
| Current Assets | $6.8M | -21.6% | +171.0% |
| Total Assets | $7.8M | -12.2% | +192.3% |
| Current Liabilities | $508K | +38.6% | -34.0% |
| Total Liabilities | $567K | +54.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | +5.9% |
| Investing Cash Flow | -$622K | — | -2561.3% |
| Financing Cash Flow | -$155K | — | -6.9% |
| -26.3% |
| Stockholders' Equity | $1.8M | -31.9% | -7.8% |